Company Profiles

driven by the PitchBook Platform

Micreos

Description

Developer of phage-based anti-bacterial products. The company develops products based on phage technology as a replacement for antibiotics in health care, veterinary medicine, the food processing industry and agriculture.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$13.3M

Latest Deal Amount

$13.3M

Total Amount Raised

Description

Developer of phage-based anti-bacterial products. The company develops products based on phage technology as a replacement for antibiotics in health care, veterinary medicine, the food processing industry and agriculture.

Website:

www.micreos.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Consumer Products and Services

Primary Office

Nieuwe Kanaal 7P 6709 WageningenNetherlands +31 (0)88 800 7151
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Micreos's full profile, request a free trial.

Micreos Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Micreos Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Altria GroupCorporationMinority000 0000000 0000
Participatiemaatschappij OostVenture CapitalMinority000 0000000 0000
Partners in EquityVenture CapitalMinority000 0000000 0000
Altria Group Corporation
Participatiemaatschappij Oost Venture Capital
Partners in Equity Venture Capital

Micreos Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Mark OfferhausChief Executive Officer & Co-Founder
Joost RietveltChief Financial Officer
Michael RiedlinChief Operating Officer
Fritz EichenseherChief Scientific Officer, Endolysins technology
Steven HagensChief Scientific Officer, Phage technology
Mark Offerhaus Chief Executive Officer & Co-Founder
Joost Rietvelt Chief Financial Officer
Michael Riedlin Chief Operating Officer
Fritz Eichenseher Chief Scientific Officer, Endolysins technology
Steven Hagens Chief Scientific Officer, Phage technology

Micreos Board Members (4)

NameRepresentingRoleSinceContact
Info
Patrick Vink MDSelfBoard Member & Clinical Development Advisor000 0000
Saskia van WalsumSelfBoard Member000 0000
Taco van der MastMicreosChairman000 0000
Ujwala WarekMicreosBoard Member000 0000
Patrick Vink MD Board Member & Clinical Development Advisor Self
Saskia van Walsum Board Member Self
Taco van der Mast Chairman Micreos
Ujwala Warek Board Member Micreos
Request full access to PitchBook